Mark M Saleh, MD
Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 059517 · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Saleh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A69469 · Current
Licensed to practise in California · since 1999 · expires 2027-03-31 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$285,029
Medicare paid this office $285,029 for 396 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 59 | $155,371 | None |
| Long return visit (40+ min) | 178 | $44,446 | $163 |
| Return visit (30+ min) | 200 | $34,628 | $114 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 59 | $22,514 | $139 |
| New patient visit (60+ min) | 46 | $9,173 | $199 |
See all 9 services
| Botox | 59 | $155,371 | None |
| Long return visit (40+ min) | 178 | $44,446 | $163 |
| Return visit (30+ min) | 200 | $34,628 | $114 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 59 | $22,514 | $139 |
| New patient visit (60+ min) | 46 | $9,173 | $199 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 311 | $7,997 | $15 |
| New patient visit (45+ min) | 42 | $6,388 | $152 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $1,046 | $40 |
| Short return visit (20+ min) | 11 | $976 | $89 |
Who their Medicare patients are
396 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 23% · Women 61% · Also on Medicaid 8% · Health risk score 1.16. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 63% · Coronary heart disease 27% · Depression 23% · Chronic kidney disease 20% · Atrial fibrillation 20% · Diabetes 18% · Cancer 15% · Dementia 13% · Heart failure 12% · Stroke 10% · COPD 6%.
The office billed $944,425, Medicare allowed $368,815 and paid $285,029; for 33,215 services of 20 kinds; $155,371 of it was for drugs given in the office and $129,659 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 396 | 33,215 | 77 | 1.16 | $944,425 | $285,029 |
| 2023 | 390 | 29,894 | 77 | 1.10 | $772,157 | $246,770 |
| 2022 | 380 | 23,491 | 77 | 1.07 | $681,239 | $214,705 |
| 2021 | 375 | 18,055 | 77 | 1.03 | $573,104 | $189,263 |
| 2020 | 303 | 16,812 | 77 | 1.15 | $472,191 | $152,285 |
| 2019 | 347 | 18,583 | 77 | 1.27 | $570,164 | $170,134 |
| 2018 | 367 | 12,134 | 78 | 1.22 | $465,383 | $136,932 |
| 2017 | 355 | 3,624 | 76 | 1.13 | $311,523 | $91,745 |
| 2016 | 336 | 4,299 | 76 | 1.09 | $317,411 | $93,182 |
| 2015 | 262 | 1,141 | 75 | 1.41 | $228,429 | $65,458 |
| 2014 | 164 | 934 | 73 | 2.58 | $282,615 | $67,905 |
| 2013 | 176 | 680 | 73 | 2.46 | $246,993 | $59,921 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Botox | 50 | $138,099 | None |
| Long return visit (40+ min) | 185 | $42,235 | $161 |
| Return visit (30+ min) | 175 | $25,645 | $109 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 51 | $20,541 | $141 |
| New patient visit (60+ min) | 57 | $10,539 | $185 |
| New patient visit (45+ min) | 36 | $5,518 | $153 |
| Short return visit (20+ min) | 18 | $1,990 | $87 |
| Short return visit | 11 | $893 | $56 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $588 | $42 |
2022: 7 services
| Botox | 39 | $106,430 | None |
| Long return visit (40+ min) | 151 | $35,746 | $159 |
| Return visit (30+ min) | 158 | $25,195 | $117 |
| New patient visit (60+ min) | 107 | $19,997 | $187 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 38 | $16,026 | $141 |
| New patient visit (45+ min) | 56 | $7,785 | $139 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $508 | $42 |
2021: 6 services
| Botox | 35 | $83,395 | None |
| Long return visit (40+ min) | 123 | $29,518 | $166 |
| Return visit (30+ min) | 167 | $28,552 | $114 |
| New patient visit (60+ min) | 105 | $20,753 | $198 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 34 | $12,354 | $145 |
| New patient visit (45+ min) | 63 | $9,603 | $152 |
2020: 9 services
| Botox | 35 | $77,862 | None |
| Long return visit (40+ min) | 101 | $18,339 | $135 |
| Return visit (30+ min) | 125 | $18,258 | $97 |
| New patient visit (60+ min) | 72 | $14,079 | $196 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 31 | $10,576 | $141 |
| New patient visit (45+ min) | 42 | $5,778 | $138 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $3,365 | $73 |
| Short return visit (20+ min) | 13 | $968 | $74 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $686 | $46 |
2019: 6 services
| Botox | 29 | $82,939 | None |
| Return visit (30+ min) | 206 | $34,950 | $96 |
| Long return visit (40+ min) | 96 | $15,873 | $126 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 28 | $11,613 | $135 |
| New patient visit (60+ min) | 59 | $10,941 | $185 |
| New patient visit (45+ min) | 74 | $10,477 | $142 |
2018: 6 services
| Botox | 31 | $54,648 | None |
| Return visit (30+ min) | 210 | $31,549 | $89 |
| Long return visit (40+ min) | 113 | $18,770 | $128 |
| New patient visit (60+ min) | 69 | $12,397 | $180 |
| New patient visit (45+ min) | 82 | $11,665 | $142 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 30 | $7,182 | $126 |
2017: 4 services
| Return visit (30+ min) | 157 | $24,841 | $92 |
| Long return visit (40+ min) | 123 | $20,970 | $128 |
| New patient visit (60+ min) | 87 | $15,548 | $179 |
| New patient visit (45+ min) | 99 | $13,331 | $135 |
2016: 4 services
| Return visit (30+ min) | 156 | $23,240 | $91 |
| Long return visit (40+ min) | 98 | $17,394 | $125 |
| New patient visit (60+ min) | 89 | $16,096 | $181 |
| New patient visit (45+ min) | 106 | $15,105 | $142 |
2015: 9 services
| Long return visit (40+ min) | 80 | $13,380 | $141 |
| Return visit (30+ min) | 96 | $12,600 | $103 |
| New patient visit (45+ min) | 45 | $7,203 | $160 |
| New patient visit (60+ min) | 34 | $6,719 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $6,108 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $5,978 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,987 | $166 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,823 | $122 |
| Short return visit (20+ min) | 11 | $768 | $64 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 105 | $24,645 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $22,109 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,543 | $90 |
| Extended inpatient or observation hospital service, first hour | 47 | $4,766 | $82 |
| Return visit (30+ min) | 11 | $2,224 | $93 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $24,585 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 120 | $20,697 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $6,306 | $90 |
| Extended inpatient or observation hospital service, first hour | 29 | $2,726 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,110 | $101 |
Drugs they prescribed that Part D paid
$654,358
Pharmacies billed $654,358 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,924 generic and 299 brand-name prescriptions · $654,358 in drug cost · 56 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nurtec Odt | 59 | $76,821 | $1,302 |
| Gocovri | 14 | $69,410 | $4,958 |
| Briviact | 25 | $48,812 | $1,952 |
| Qulipta | 32 | $39,564 | $1,236 |
| Nourianz | 19 | $35,362 | $1,861 |
See all 47 drugs
| Nurtec Odt | None | 59 | $76,821 | $1,302 |
| Gocovri | None | 14 | $69,410 | $4,958 |
| Briviact | None | 25 | $48,812 | $1,952 |
| Qulipta | None | 32 | $39,564 | $1,236 |
| Nourianz | None | 19 | $35,362 | $1,861 |
| Xcopri | None | 23 | $26,444 | $1,150 |
| Ubrelvy | None | 18 | $24,690 | $1,372 |
| Rytary | Parkinson's | 14 | $14,925 | $1,066 |
| Rasagiline Mesylate | None | 61 | $14,486 | $237 |
| Carbidopa-Levodopa | None | 329 | $12,890 | $39 |
| Sumatriptan | None | 82 | $9,327 | $114 |
| Eliquis | None | 11 | $6,213 | $565 |
| Entacapone | None | 14 | $5,650 | $404 |
| Gabapentin | None | 192 | $5,452 | $28 |
| Carbamazepine Er | None | 20 | $4,931 | $247 |
| Levetiracetam | None | 66 | $4,644 | $70 |
| Rivastigmine | None | 12 | $3,976 | $331 |
| Levetiracetam Er | None | 17 | $3,918 | $230 |
| Donepezil | None | 205 | $2,640 | $13 |
| Pregabalin | None | 26 | $2,526 | $97 |
| Memantine | None | 81 | $2,151 | $27 |
| Escitalopram | None | 134 | $1,592 | $12 |
| Primidone | None | 51 | $1,459 | $29 |
| Mirtazapine | None | 59 | $1,388 | $24 |
| Modafinil | None | 16 | $1,041 | $65 |
| Quetiapine | None | 48 | $1,022 | $21 |
| Ropinirole | None | 12 | $1,004 | $84 |
| Propranolol Hcl Er | None | 24 | $964 | $40 |
| Naratriptan | None | 20 | $713 | $36 |
| Divalproex | None | 13 | $615 | $47 |
| Topiramate | None | 33 | $542 | $16 |
| Lamotrigine | None | 15 | $524 | $35 |
| Trazodone | None | 33 | $445 | $13 |
| Propranolol | None | 14 | $432 | $31 |
| Nortriptyline | None | 13 | $371 | $29 |
| Cyproheptadine | None | 13 | $357 | $27 |
| Phenobarbital | None | 11 | $327 | $30 |
| Amitriptyline | None | 18 | $295 | $16 |
| Baclofen | None | 11 | $289 | $26 |
| Clopidogrel | None | 13 | $253 | $19 |
| Butalbital-Acetaminophen-Caffe | None | 14 | $213 | $15 |
| Rizatriptan | None | 15 | $211 | $14 |
| Lorazepam | None | 23 | $159 | $7 |
| Promethazine | None | 11 | $80 | $7 |
| Atorvastatin | None | 12 | $41 | $3 |
| Cyclobenzaprine | None | 11 | $31 | $3 |
| Sertraline | None | 12 | $28 | $2 |
Year by year
| 2024 | 2,234 | 352 | None | 13% | $654,358 |
| 2023 | 2,131 | 344 | 1% (13) | None | $584,403 |
| 2022 | 2,063 | 342 | 1% (14) | None | $474,856 |
| 2021 | 1,800 | 286 | None | None | $357,616 |
| 2020 | 1,559 | 249 | 2% (24) | None | $294,884 |
| 2019 | 1,512 | 266 | 2% (36) | None | $231,557 |
| 2018 | 1,602 | 268 | 2% (32) | 9% | $226,014 |
| 2017 | 1,361 | 251 | 2% (28) | 11% | $190,874 |
| 2016 | 1,055 | 200 | 1% (15) | None | $157,462 |
| 2015 | 390 | 113 | None | 20% | $71,013 |
| 2014 | 185 | 32 | None | None | $16,284 |
| 2013 | 275 | 85 | None | None | $40,967 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 44 drugs
| Nurtec Odt | None | 67 | $90,218 | $1,347 |
| Briviact | None | 25 | $42,376 | $1,695 |
| Gocovri | None | 12 | $41,521 | $3,460 |
| Qulipta | None | 27 | $34,606 | $1,282 |
| Nourianz | None | 11 | $20,939 | $1,904 |
| Carbidopa-Levodopa | None | 317 | $19,234 | $61 |
| Rasagiline Mesylate | None | 56 | $14,320 | $256 |
| Emgality | Migraine | 17 | $12,823 | $754 |
| Eliquis | None | 15 | $8,995 | $600 |
| Levetiracetam Er | None | 28 | $8,470 | $303 |
| Gabapentin | None | 184 | $6,447 | $35 |
| Entacapone | None | 22 | $5,927 | $269 |
| Carbamazepine Er | None | 19 | $5,506 | $290 |
| Memantine | None | 69 | $5,431 | $79 |
| Levetiracetam | None | 62 | $4,512 | $73 |
| Dimethyl | None | 11 | $3,212 | $292 |
| Donepezil | None | 180 | $2,923 | $16 |
| Primidone | None | 60 | $2,384 | $40 |
| Ropinirole | None | 13 | $1,840 | $142 |
| Sumatriptan | None | 68 | $1,807 | $27 |
| Lacosamide | None | 16 | $1,628 | $102 |
| Quetiapine | None | 65 | $1,613 | $25 |
| Escitalopram | None | 97 | $1,570 | $16 |
| Propranolol Hcl Er | None | 19 | $1,508 | $79 |
| Divalproex | None | 15 | $1,472 | $98 |
| Pregabalin | None | 26 | $1,445 | $56 |
| Memantine Hcl Er | None | 12 | $1,317 | $110 |
| Donepezil Hcl Odt | None | 12 | $1,248 | $104 |
| Mirtazapine | None | 54 | $1,056 | $20 |
| Propranolol | None | 21 | $934 | $44 |
| Naratriptan | None | 16 | $880 | $55 |
| Divalproex Sodium Er | None | 11 | $846 | $77 |
| Methylphenidate | None | 12 | $721 | $60 |
| Lorazepam | None | 13 | $504 | $39 |
| Pramipexole Dihydrochloride | None | 11 | $492 | $45 |
| Topiramate | None | 36 | $465 | $13 |
| Amitriptyline | None | 19 | $441 | $23 |
| Phenytoin Sodium Extended | None | 15 | $433 | $29 |
| Clopidogrel | None | 12 | $320 | $27 |
| Modafinil | None | 11 | $259 | $24 |
| Trazodone | None | 14 | $248 | $18 |
| Atorvastatin | None | 21 | $176 | $8 |
| Sertraline | None | 17 | $166 | $10 |
| Ondansetron | None | 12 | $141 | $12 |
2022: 49 drugs
| Nurtec Odt | None | 43 | $55,077 | $1,281 |
| Briviact | None | 24 | $41,525 | $1,730 |
| Gocovri | None | 12 | $37,352 | $3,113 |
| Nourianz | None | 21 | $36,379 | $1,732 |
| Qulipta | None | 22 | $22,814 | $1,037 |
| Ubrelvy | None | 11 | $21,105 | $1,919 |
| Carbidopa | None | 11 | $18,157 | $1,651 |
| Carbidopa-Levodopa | None | 301 | $16,280 | $54 |
| Glatiramer Acetate | None | 12 | $15,454 | $1,288 |
| Emgality | Migraine | 17 | $15,213 | $895 |
| Rasagiline Mesylate | None | 45 | $11,437 | $254 |
| Eliquis | None | 15 | $11,011 | $734 |
| Carbamazepine Er | None | 32 | $7,907 | $247 |
| Lacosamide | None | 11 | $6,401 | $582 |
| Dimethyl | None | 11 | $5,957 | $542 |
| Levetiracetam | None | 91 | $5,724 | $63 |
| Gabapentin | None | 184 | $5,631 | $31 |
| Memantine | None | 45 | $4,645 | $103 |
| Entacapone | None | 11 | $3,746 | $341 |
| Levetiracetam Er | None | 26 | $3,682 | $142 |
| Pregabalin | None | 27 | $2,897 | $107 |
| Primidone | None | 63 | $2,662 | $42 |
| Donepezil | None | 164 | $2,189 | $13 |
| Escitalopram | None | 113 | $1,804 | $16 |
| Divalproex | None | 19 | $1,351 | $71 |
| Propranolol Hcl Er | None | 25 | $1,185 | $47 |
| Ropinirole | None | 15 | $1,076 | $72 |
| Amantadine | None | 13 | $1,071 | $82 |
| Mirtazapine | None | 69 | $999 | $14 |
| Propranolol | None | 21 | $952 | $45 |
| Topiramate | None | 33 | $792 | $24 |
| Sumatriptan | None | 36 | $700 | $19 |
| Naratriptan | None | 14 | $658 | $47 |
| Quetiapine | None | 54 | $620 | $11 |
| Amitriptyline | None | 12 | $587 | $49 |
| Phenytoin Sodium Extended | None | 19 | $583 | $31 |
| Atorvastatin | None | 28 | $559 | $20 |
| Nortriptyline | None | 20 | $476 | $24 |
| Lorazepam | None | 14 | $443 | $32 |
| Modafinil | None | 14 | $385 | $28 |
| Pramipexole Dihydrochloride | None | 15 | $355 | $24 |
| Donepezil Hcl Odt | None | 12 | $315 | $26 |
| Zolpidem Tartrate Er | None | 15 | $203 | $14 |
| Trazodone | None | 23 | $145 | $6 |
| Levothyroxine | None | 13 | $117 | $9 |
| Acetaminophen-Codeine | None | 11 | $112 | $10 |
| Sertraline | None | 17 | $96 | $6 |
| Fluoxetine | None | 12 | $52 | $4 |
| Lovastatin | None | 12 | $47 | $4 |
2021: 37 drugs
| Briviact | 21 | $34,944 | $1,664 |
| Ubrelvy | 24 | $21,860 | $911 |
| Carbidopa-Levodopa | 284 | $21,675 | $76 |
| Neupro | 28 | $21,180 | $756 |
| Rasagiline Mesylate | 39 | $19,612 | $503 |
| Nurtec Odt | 17 | $15,764 | $927 |
| Ajovy | 12 | $12,576 | $1,048 |
| Carbidopa | 12 | $11,514 | $960 |
| Sumatriptan | 58 | $9,760 | $168 |
| Eliquis | 15 | $9,594 | $640 |
| Carbamazepine Er | 42 | $7,078 | $169 |
| Lidocaine | 15 | $5,758 | $384 |
| Carbidopa-Levodopa-Entacapone | 11 | $5,532 | $503 |
| Memantine | 31 | $4,219 | $136 |
| Gabapentin | 156 | $4,197 | $27 |
| Levetiracetam Er | 26 | $3,984 | $153 |
| Levetiracetam | 67 | $3,911 | $58 |
| Primidone | 65 | $2,780 | $43 |
| Pregabalin | 18 | $1,922 | $107 |
| Topiramate | 43 | $1,885 | $44 |
| Escitalopram | 131 | $1,784 | $14 |
| Memantine Hcl Er | 12 | $1,609 | $134 |
| Donepezil | 117 | $1,247 | $11 |
| Quetiapine | 49 | $1,076 | $22 |
| Divalproex | 20 | $1,031 | $52 |
| Mirtazapine | 71 | $969 | $14 |
| Phenytoin Sodium Extended | 19 | $815 | $43 |
| Propranolol | 12 | $763 | $64 |
| Amitriptyline | 16 | $617 | $39 |
| Nortriptyline | 15 | $564 | $38 |
| Atorvastatin | 32 | $495 | $15 |
| Lorazepam | 21 | $384 | $18 |
| Trazodone | 19 | $289 | $15 |
| Propranolol Hcl Er | 11 | $275 | $25 |
| Levothyroxine | 16 | $168 | $10 |
| Zolpidem Tartrate Er | 15 | $134 | $9 |
| Sertraline | 12 | $55 | $5 |
2020: 36 drugs
| Briviact | 30 | $36,444 | $1,215 |
| Gocovri | 11 | $30,941 | $2,813 |
| Trokendi Xr | 16 | $21,096 | $1,318 |
| Rasagiline Mesylate | 32 | $21,042 | $658 |
| Vimpat | 11 | $14,384 | $1,308 |
| Carbidopa-Levodopa | 202 | $14,198 | $70 |
| Ubrelvy | 11 | $12,402 | $1,127 |
| Ajovy | 13 | $9,357 | $720 |
| Carbamazepine Er | 29 | $4,976 | $172 |
| Levetiracetam | 80 | $4,135 | $52 |
| Gabapentin | 149 | $3,698 | $25 |
| Memantine | 40 | $3,615 | $90 |
| Lidocaine | 15 | $3,404 | $227 |
| Sumatriptan | 38 | $2,655 | $70 |
| Entacapone | 11 | $2,201 | $200 |
| Primidone | 55 | $2,136 | $39 |
| Memantine Hcl Er | 15 | $1,972 | $131 |
| Levetiracetam Er | 23 | $1,683 | $73 |
| Divalproex Sodium Er | 12 | $1,455 | $121 |
| Pregabalin | 15 | $1,233 | $82 |
| Donepezil | 75 | $1,180 | $16 |
| Topiramate | 41 | $1,126 | $27 |
| Mirtazapine | 44 | $1,016 | $23 |
| Escitalopram | 116 | $1,008 | $9 |
| Quetiapine | 54 | $989 | $18 |
| Phenytoin Sodium Extended | 22 | $976 | $44 |
| Nortriptyline | 15 | $782 | $52 |
| Divalproex | 32 | $726 | $23 |
| Amitriptyline | 21 | $704 | $34 |
| Atorvastatin | 38 | $452 | $12 |
| Propranolol Hcl Er | 12 | $323 | $27 |
| Lorazepam | 15 | $304 | $20 |
| Cyproheptadine | 14 | $157 | $11 |
| Levothyroxine | 12 | $112 | $9 |
| Zolpidem Tartrate Er | 11 | $92 | $8 |
| Sertraline | 12 | $89 | $7 |
2019: 32 drugs
| Rasagiline Mesylate | 44 | $29,206 | $664 |
| Trokendi Xr | 12 | $20,175 | $1,681 |
| Briviact | 13 | $15,613 | $1,201 |
| Carbidopa-Levodopa | 230 | $14,129 | $61 |
| Lyrica | 11 | $9,943 | $904 |
| Memantine Hcl Er | 15 | $5,230 | $349 |
| Levetiracetam Er | 35 | $4,729 | $135 |
| Memantine | 57 | $4,096 | $72 |
| Levetiracetam | 100 | $3,927 | $39 |
| Gabapentin | 153 | $3,714 | $24 |
| Donepezil | 89 | $3,015 | $34 |
| Carbamazepine Er | 16 | $2,987 | $187 |
| Mirtazapine | 19 | $1,258 | $66 |
| Sumatriptan | 23 | $1,257 | $55 |
| Divalproex Sodium Er | 16 | $1,081 | $68 |
| Quetiapine | 58 | $973 | $17 |
| Amitriptyline | 37 | $953 | $26 |
| Topiramate | 32 | $906 | $28 |
| Duloxetine | 13 | $880 | $68 |
| Escitalopram | 67 | $873 | $13 |
| Amantadine | 15 | $804 | $54 |
| Phenytoin Sodium Extended | 20 | $715 | $36 |
| Primidone | 27 | $596 | $22 |
| Propranolol Hcl Er | 14 | $440 | $31 |
| Cyproheptadine | 24 | $389 | $16 |
| Atorvastatin | 24 | $383 | $16 |
| Divalproex | 14 | $342 | $24 |
| Lorazepam | 16 | $303 | $19 |
| Clopidogrel | 18 | $206 | $11 |
| Bupropion Hcl Sr | 11 | $133 | $12 |
| Sertraline | 12 | $98 | $8 |
| Acetaminophen-Codeine | 11 | $88 | $8 |
2018: 35 drugs
| Nuplazid | Parkinson's psychosis | 11 | $32,683 | $2,971 |
| Rasagiline Mesylate | None | 46 | $28,569 | $621 |
| Neurontin | None | 12 | $16,177 | $1,348 |
| Briviact | None | 13 | $13,498 | $1,038 |
| Carbidopa-Levodopa | None | 214 | $11,155 | $52 |
| Trokendi Xr | None | 13 | $7,290 | $561 |
| Memantine | None | 70 | $6,488 | $93 |
| Levetiracetam | None | 111 | $4,445 | $40 |
| Gabapentin | None | 144 | $3,535 | $25 |
| Carbamazepine Er | None | 11 | $2,985 | $271 |
| Amantadine | None | 31 | $2,725 | $88 |
| Dilantin | None | 12 | $1,707 | $142 |
| Donepezil | None | 125 | $1,702 | $14 |
| Levetiracetam Er | None | 30 | $1,629 | $54 |
| Divalproex Sodium Er | None | 21 | $1,174 | $56 |
| Amitriptyline | None | 39 | $966 | $25 |
| Topiramate | None | 57 | $885 | $16 |
| Mirtazapine | None | 33 | $662 | $20 |
| Quetiapine | None | 50 | $649 | $13 |
| Nortriptyline | None | 28 | $624 | $22 |
| Pyridostigmine | None | 11 | $606 | $55 |
| Escitalopram | None | 40 | $521 | $13 |
| Atorvastatin | None | 25 | $482 | $19 |
| Phenobarbital | None | 12 | $481 | $40 |
| Zolpidem Tartrate Er | None | 13 | $456 | $35 |
| Pramipexole Dihydrochloride | None | 17 | $454 | $27 |
| Propranolol Hcl Er | None | 15 | $367 | $24 |
| Primidone | None | 29 | $350 | $12 |
| Lorazepam | None | 14 | $260 | $19 |
| Cyproheptadine | None | 15 | $260 | $17 |
| Trazodone | None | 16 | $251 | $16 |
| Sumatriptan | None | 22 | $248 | $11 |
| Baclofen | None | 12 | $140 | $12 |
| Fluoxetine | None | 13 | $38 | $3 |
| Tramadol | None | 11 | $28 | $3 |
2017: 31 drugs
| Rasagiline Mesylate | 41 | $27,141 | $662 |
| Vimpat | 20 | $17,406 | $870 |
| Namenda Xr | 18 | $16,187 | $899 |
| Neurontin | 12 | $13,493 | $1,124 |
| Carbidopa-Levodopa | 190 | $8,622 | $45 |
| Memantine | 74 | $6,670 | $90 |
| Levetiracetam | 119 | $3,480 | $29 |
| Rivastigmine | 11 | $2,857 | $260 |
| Gabapentin | 108 | $2,283 | $21 |
| Amantadine | 22 | $1,900 | $86 |
| Modafinil | 11 | $1,642 | $149 |
| Amitriptyline | 40 | $1,303 | $33 |
| Verapamil Er | 22 | $1,249 | $57 |
| Donepezil | 87 | $1,062 | $12 |
| Levetiracetam Er | 18 | $1,022 | $57 |
| Divalproex Sodium Er | 12 | $842 | $70 |
| Duloxetine | 11 | $713 | $65 |
| Escitalopram | 41 | $572 | $14 |
| Nortriptyline | 39 | $553 | $14 |
| Zolpidem Tartrate Er | 12 | $544 | $45 |
| Sumatriptan | 22 | $476 | $22 |
| Topiramate | 56 | $463 | $8 |
| Phenobarbital | 12 | $462 | $39 |
| Phenytoin Sodium Extended | 14 | $393 | $28 |
| Lorazepam | 14 | $318 | $23 |
| Atorvastatin | 17 | $289 | $17 |
| Primidone | 19 | $275 | $14 |
| Quetiapine | 14 | $154 | $11 |
| Mirtazapine | 21 | $152 | $7 |
| Sertraline | 14 | $142 | $10 |
| Finasteride | 13 | $72 | $6 |
2016: 20 drugs
| Azilect | 19 | $20,119 | $1,059 |
| Namenda Xr | 32 | $16,702 | $522 |
| Neurontin | 12 | $10,897 | $908 |
| Lyrica | 16 | $7,601 | $475 |
| Vimpat | 12 | $7,245 | $604 |
| Carbidopa-Levodopa | 131 | $4,454 | $34 |
| Gabapentin | 156 | $3,585 | $23 |
| Memantine | 43 | $3,041 | $71 |
| Levetiracetam | 96 | $2,100 | $22 |
| Donepezil | 74 | $1,023 | $14 |
| Amitriptyline | 34 | $953 | $28 |
| Escitalopram | 43 | $555 | $13 |
| Topiramate | 54 | $491 | $9 |
| Atorvastatin | 15 | $372 | $25 |
| Nortriptyline | 24 | $334 | $14 |
| Clopidogrel | 15 | $237 | $16 |
| Primidone | 16 | $210 | $13 |
| Sumatriptan | 11 | $102 | $9 |
| Mirtazapine | 12 | $70 | $6 |
| Tramadol | 12 | $61 | $5 |
2015: 10 drugs
| Namenda Xr | 16 | $5,755 | $360 |
| Vesicare | 17 | $4,073 | $240 |
| Gabapentin | 69 | $1,827 | $26 |
| Carbidopa-Levodopa | 25 | $833 | $33 |
| Levetiracetam | 25 | $551 | $22 |
| Tamsulosin | 25 | $427 | $17 |
| Amitriptyline | 19 | $297 | $16 |
| Escitalopram | 13 | $95 | $7 |
| Topiramate | 12 | $85 | $7 |
| Donepezil | 11 | $84 | $8 |
2014: 5 drugs
| Vesicare | 22 | $4,829 | $219 |
| Levetiracetam | 17 | $708 | $42 |
| Gabapentin | 24 | $454 | $19 |
| Tamsulosin | 22 | $438 | $20 |
| Carbidopa-Levodopa | 13 | $384 | $30 |
2013: 5 drugs
| Vesicare | 20 | $5,084 | $254 |
| Donepezil | 37 | $746 | $20 |
| Carbidopa-Levodopa | 19 | $682 | $36 |
| Tamsulosin | 22 | $539 | $25 |
| Amitriptyline | 16 | $147 | $9 |
Money from drug and device companies
$11,511 in 2025
| 2025 | 21 | 164 | $6,400 | $11,511 |
| 2024 | 20 | 134 | None | $3,746 |
| 2023 | 13 | 109 | $150 | $2,120 |
| 2022 | 9 | 30 | None | $841 |
| 2021 | 15 | 64 | $300 | $1,412 |
| 2020 | 11 | 70 | None | $856 |
| 2019 | 13 | 81 | $17 | $1,075 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SK Life Science | Xcopri | $8,130 | 34 payments
|
| Abbvie | Botox | $745 | 33 payments
|
| Neurocrine BioSciences | Ingrezza | $412 | 9 payments
|
| Pfizer | Nurtec Odt | $384 | 19 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $338 | 12 payments
|
| Biogen | Tysabri | $224 | 5 payments
|
See all 164 published payments
| Pfizer | Meals · 2025-12-23 | Nurtec Odt | $4 |
| Neurocrine BioSciences | Meals · 2025-12-20 | Ingrezza | $37 |
| Axsome Therapeutics | Meals · 2025-12-17 | Symbravo | $15 |
| Amgen | Meals · 2025-12-16 | Uplizna | $33 |
| Pfizer | Meals · 2025-12-16 | Nurtec Odt | $12 |
| Merz Pharmaceuticals | Meals · 2025-12-15 | Inbrija | $23 |
| Abbvie | Meals · 2025-12-11 | Vyalev | $30 |
| Abbvie | Meals · 2025-12-10 | Botox | $24 |
| Ucb | Meals · 2025-12-09 | Rystiggo | $25 |
| Lundbeck | Meals · 2025-12-05 | Rexulti | $32 |
| Abbvie | Meals · 2025-12-04 | Qulipta | $6 |
| Pfizer | Meals · 2025-12-03 | Nurtec Odt | $22 |
| CSL Behring | Meals · 2025-12-03 | Hizentra | $22 |
| SK Life Science | Meals · 2025-12-03 | None | $13 |
| SK Life Science | Meals · 2025-11-19 | None | $28 |
| Alexion Pharmaceuticals | Meals · 2025-11-18 | None | $132 |
| Abbvie | Meals · 2025-11-18 | Qulipta | $11 |
| Neurelis | Meals · 2025-11-18 | Valtoco | $36 |
| Novartis Pharmaceuticals | Meals · 2025-11-13 | Kesimpta | $14 |
| Pfizer | Meals · 2025-11-12 | Aromasin | $18 |
| Abbvie | Meals · 2025-11-11 | Qulipta | $19 |
| SK Life Science | Meals · 2025-11-07 | None | $14 |
| Amneal Pharmaceuticals | Meals · 2025-11-06 | Crexont | $23 |
| Axsome Therapeutics | Meals · 2025-11-05 | Symbravo | $22 |
| Pfizer | Meals · 2025-11-04 | Nurtec Odt | $14 |
| Teva Pharmaceuticals USA | Education · 2025-11-04 | None | $88 |
| Teva Pharmaceuticals USA | Meals · 2025-11-04 | Austedo Xr | $36 |
| Pfizer | Meals · 2025-10-30 | Nurtec Odt | $26 |
| SK Life Science | Meals · 2025-10-30 | None | $25 |
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Kesimpta | $14 |
| Ucb | Meals · 2025-10-28 | Rystiggo | $15 |
| Lundbeck | Meals · 2025-10-25 | Rexulti | $30 |
| Abbvie | Meals · 2025-10-24 | Botox | $28 |
| Abbvie | Meals · 2025-10-22 | Qulipta | $11 |
| Genentech USA | Meals · 2025-10-21 | Ocrevus Zunovo | $19 |
| Pfizer | Meals · 2025-10-17 | Nurtec Odt | $6 |
| Neurelis | Meals · 2025-10-15 | Valtoco | $36 |
| Neurocrine BioSciences | Meals · 2025-10-15 | Ingrezza | $39 |
| Pfizer | Meals · 2025-10-10 | Nurtec Odt | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-10-07 | Ajovy | $21 |
| Merz Pharmaceuticals | Meals · 2025-10-06 | Xeomin | $26 |
| Abbvie | Meals · 2025-10-02 | Ubrelvy | $21 |
| SK Life Science | Meals · 2025-10-02 | None | $12 |
| Amgen | Meals · 2025-09-26 | Uplizna | $23 |
| Ucb | Meals · 2025-09-19 | Rystiggo | $34 |
| MDD US Operations | Meals · 2025-09-16 | None | $16 |
| SK Life Science | Meals · 2025-09-16 | None | $14 |
| Abbvie | Meals · 2025-09-04 | Botox | $30 |
| SK Life Science | Meals · 2025-09-03 | None | $12 |
| Neurelis | Meals · 2025-09-02 | Valtoco | $22 |
| Pfizer | Meals · 2025-08-29 | Nurtec Odt | $18 |
| Biogen | Meals · 2025-08-28 | Tysabri | $21 |
| Biogen | Meals · 2025-08-28 | Tysabri | $3 |
| Neurocrine BioSciences | Meals · 2025-08-27 | Ingrezza | $140 |
| Neurocrine BioSciences | Meals · 2025-08-27 | Ingrezza | $36 |
| Novartis Pharmaceuticals | Meals · 2025-08-21 | Kesimpta | $19 |
| Ucb | Meals · 2025-08-21 | Rystiggo | $31 |
| Lundbeck | Meals · 2025-08-21 | Rexulti | $35 |
| SK Life Science | Meals · 2025-08-19 | None | $13 |
| Abbvie | Meals · 2025-08-14 | Qulipta | $14 |
| Neurelis | Meals · 2025-08-13 | Valtoco | $41 |
| Pfizer | Meals · 2025-08-12 | Nurtec Odt | $10 |
| Pfizer | Meals · 2025-08-07 | Nurtec Odt | $15 |
| Abbvie | Meals · 2025-08-06 | Botox | $30 |
| SK Life Science | Meals · 2025-08-04 | None | $14 |
| Neurocrine BioSciences | Meals · 2025-07-30 | Ingrezza | $40 |
| Novartis Pharmaceuticals | Meals · 2025-07-25 | Kesimpta | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-07-24 | Austedo Xr | $35 |
| Abbvie | Meals · 2025-07-23 | Botox | $20 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-07-23 | Rexulti | $28 |
| SK Life Science | Meals · 2025-07-22 | None | $31 |
| SK Life Science | Meals · 2025-07-22 | None | $6 |
| Neurocrine BioSciences | Meals · 2025-07-16 | Ingrezza | $13 |
| Pfizer | Meals · 2025-07-14 | Nurtec Odt | $11 |
| TG Therapeutics | Meals · 2025-06-26 | Briumvi | $33 |
| Pfizer | Meals · 2025-06-25 | Nurtec Odt | $9 |
| SK Life Science | Meals · 2025-06-24 | None | $13 |
| MDD US Operations | Meals · 2025-06-19 | None | $17 |
| Merz Pharmaceuticals | Meals · 2025-06-16 | Xeomin | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-06-16 | Austedo Xr | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-06-16 | Austedo Xr | $12 |
| Pfizer | Meals · 2025-06-12 | Zavzpret | $108 |
| Neurelis | Meals · 2025-06-11 | Valtoco | $33 |
| SK Life Science | Meals · 2025-06-11 | None | $15 |
| Otsuka America Pharmaceutical | Meals · 2025-06-10 | Rexulti | $19 |
| Pfizer | Meals · 2025-06-03 | Nurtec Odt | $18 |
| Ucb | Meals · 2025-05-28 | Rystiggo | $24 |
| Biogen | Consulting · 2025-05-21 | Tysabri | $150 |
| Abbvie | Meals · 2025-05-14 | Botox | $19 |
| Abbvie | Meals · 2025-05-10 | Ubrelvy | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-05-08 | Austedo Xr | $43 |
| SK Life Science | Meals · 2025-05-08 | None | $12 |
| Amneal Pharmaceuticals | Meals · 2025-05-06 | Rytary | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-05-06 | Rexulti | $18 |
| Ucb | Meals · 2025-05-01 | Rystiggo | $1 |
| Ucb | Meals · 2025-05-01 | Rystiggo | $11 |
| Pfizer | Meals · 2025-04-30 | Nurtec Odt | $26 |
| Neurocrine BioSciences | Meals · 2025-04-30 | Ingrezza | $35 |
| Abbvie | Meals · 2025-04-28 | Botox | $11 |
| Abbvie | Meals · 2025-04-26 | Ubrelvy | $35 |
| TG Therapeutics | Meals · 2025-04-22 | Briumvi | $21 |
| Pfizer | Meals · 2025-04-22 | Nurtec Odt | $9 |
| Lundbeck | Meals · 2025-04-17 | Rexulti | $27 |
| SK Life Science | Meals · 2025-04-16 | None | $12 |
| SK Life Science | Meals · 2025-04-11 | None | $20 |
| Teva Pharmaceuticals USA | Meals · 2025-04-09 | Austedo Xr | $24 |
| Abbvie | Meals · 2025-04-08 | Ubrelvy | $29 |
| Neurelis | Meals · 2025-04-08 | Valtoco | $34 |
| Abbvie | Meals · 2025-04-04 | Botox | $30 |
| Abbvie | Meals · 2025-03-28 | Botox | $32 |
| Ucb | Meals · 2025-03-28 | Zilbrysq | $10 |
| Ucb | Meals · 2025-03-28 | Zilbrysq | $14 |
| SK Life Science | Travel · 2025-03-28 | Xcopri | $231 |
| Otsuka America Pharmaceutical | Meals · 2025-03-26 | Rexulti | $21 |
| Abbvie | Meals · 2025-03-25 | Ubrelvy | $29 |
| Ucb | Meals · 2025-03-21 | Rystiggo | $10 |
| Ucb | Meals · 2025-03-21 | Rystiggo | $11 |
| SK Life Science | Travel · 2025-03-21 | Xcopri | $114 |
| SK Life Science | Meals · 2025-03-21 | Xcopri | $37 |
| Abbvie | Meals · 2025-03-20 | Ubrelvy | $16 |
| Amneal Pharmaceuticals | Meals · 2025-03-19 | Rytary | $19 |
| Biogen | Meals · 2025-03-18 | Vumerity | $26 |
| SK Life Science | Honoraria · 2025-03-14 | Xcopri | $6,250 |
| Abbvie | Meals · 2025-03-13 | Botox | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-03-13 | Ajovy | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-03-13 | Austedo Xr | $30 |
| Pfizer | Meals · 2025-03-12 | Nurtec Odt | $17 |
| SK Life Science | Meals · 2025-03-12 | None | $32 |
| Abbvie | Meals · 2025-03-08 | Ubrelvy | $31 |
| Novartis Pharmaceuticals | Meals · 2025-03-04 | Kesimpta | $21 |
| Abbvie | Meals · 2025-03-04 | Qulipta | $17 |
| SK Life Science | Travel · 2025-03-02 | Xcopri | $345 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $28 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $100 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $40 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $45 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $28 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $65 |
| SK Life Science | Meals · 2025-03-02 | Xcopri | $53 |
| Abbvie | Meals · 2025-02-27 | Ubrelvy | $30 |
| Neurocrine BioSciences | Meals · 2025-02-26 | Ingrezza | $36 |
| Neurelis | Meals · 2025-02-25 | Valtoco | $10 |
| Neurelis | Meals · 2025-02-25 | Valtoco | $13 |
| Pfizer | Meals · 2025-02-24 | Nurtec Odt | $24 |
| MDD US Operations | Meals · 2025-02-22 | None | $33 |
| SK Life Science | Meals · 2025-02-21 | None | $17 |
| Abbvie | Meals · 2025-02-20 | Botox | $35 |
| Teva Pharmaceuticals USA | Meals · 2025-02-20 | Austedo Xr | $28 |
| Abbvie | Meals · 2025-02-19 | Qulipta | $18 |
| SK Life Science | Travel · 2025-02-12 | Xcopri | $430 |
| SK Life Science | Travel · 2025-02-12 | Xcopri | $40 |
| Otsuka America Pharmaceutical | Meals · 2025-02-11 | Rexulti | $25 |
| MDD US Operations | Meals · 2025-02-10 | None | $14 |
| Abbvie | Meals · 2025-02-06 | Qulipta | $30 |
| Biogen | Meals · 2025-02-06 | Vumerity | $24 |
| Abbvie | Meals · 2025-01-30 | Qulipta | $27 |
| SK Life Science | Meals · 2025-01-30 | None | $11 |
| Neurocrine BioSciences | Meals · 2025-01-29 | Ingrezza | $36 |
| Abbvie | Meals · 2025-01-24 | Qulipta | $16 |
| Abbvie | Meals · 2025-01-16 | Botox | $11 |
| Abbvie | Meals · 2025-01-15 | Botox | $16 |
| Abbvie | Meals · 2025-01-15 | Ubrelvy | $23 |
| Teva Pharmaceuticals USA | Meals · 2025-01-15 | Austedo Xr | $14 |
| SK Life Science | Meals · 2025-01-14 | None | $12 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,746
| Abbvie | Ubrelvy | $1,206 | 46 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $387 | 15 payments
|
| MDD US Operations | Gocovri | $369 | 13 payments
|
| Neurocrine Biosciences | Ingrezza | $334 | 7 payments
|
| SK Life Science | Xcopri | $261 | 21 payments
|
| Amgen | Uplizna | $148 | 2 payments
|
| Axsome Therapeutics | Auvelity | $134 | 1 payment
|
| Eisai | Leqembi | $125 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $122 | 1 payment
|
| Ucb | Rystiggo | $108 | 3 payments
|
| Lilly USA | Emgality | $92 | 4 payments
|
| Novartis Pharmaceuticals | Kesimpta | $83 | 4 payments
|
| Banner Life Sciences | Bafiertam | $83 | 4 payments
|
| Pfizer | Nurtec Odt | $67 | 4 payments
|
| Sumitomo Pharma America | Aptiom | $52 | 2 payments
|
| Biogen | Tysabri | $49 | 2 payments
|
| Neurelis | Valtoco | $47 | 1 payment
|
| Lundbeck | Vyepti | $32 | 1 payment
|
| Acorda Therapeutics | Inbrija | $26 | 1 payment
|
| Amneal Pharmaceuticals | Unithroid | $22 | 1 payment
|
2023: $2,120
| AbbVie | Qulipta | $667 | 35 payments
|
| Impel Pharmaceuticals | Trudhesa | $499 | 46 payments
|
| Biogen | Tysabri | $243 | 2 payments
|
| Pfizer | Zavzpret | $202 | 10 payments
|
| Astellas Pharma US | None | $94 | 1 payment
|
| MDD US Operations | None | $86 | 3 payments
|
| Sumitomo Pharma America | Aptiom | $83 | 4 payments
|
| Alexion Pharmaceuticals | None | $60 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $55 | 2 payments
|
| Genentech USA | Enspryng | $49 | 2 payments
|
| SK Life Science | None | $30 | 1 payment
|
| Lilly USA | Emgality | $27 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $25 | 1 payment
|
2022: $841
| Abbvie | Botox | $282 | 11 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $161 | 10 payments
|
| Impel Pharmaceuticals | Trudhesa | $119 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $96 | 1 payment
|
| Astellas Pharma US | None | $85 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $46 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $19 | 1 payment
|
| Ucb | Briviact | $19 | 1 payment
|
| Lilly USA | Emgality | $15 | 1 payment
|
2021: $1,412
| Biogen | Tysabri | $388 | 6 payments
|
| AbbVie | Ubrelvy | $175 | 17 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $164 | 8 payments
|
| Teva Pharmaceuticals USA | Ajovy | $125 | 6 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $73 | 5 payments
|
| Kyowa Kirin | Nourianz | $69 | 4 payments
|
| Alexion Pharmaceuticals | Soliris | $69 | 3 payments
|
| Amgen | Aimovig | $66 | 2 payments
|
| Ucb | Briviact | $63 | 3 payments
|
| Lilly USA | Emgality | $51 | 3 payments
|
| Novartis Pharmaceuticals | Kesimpta | $45 | 2 payments
|
| Allergan | Botox | $45 | 2 payments
|
| Adamas Pharmaceuticals | Gocovri | $31 | 1 payment
|
| SK Life Science | Xcopri | $25 | 1 payment
|
| Lundbeck | Vyepti | $22 | 1 payment
|
2020: $856
| EMD Serono | Mavenclad | $150 | 15 payments
|
| Sunovion Pharmaceuticals | Aptiom | $140 | 13 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $133 | 16 payments
|
| Allergan | Ubrelvy | $133 | 12 payments
|
| Ucb | Briviact | $92 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $56 | 2 payments
|
| Avanir Pharmaceuticals | Nuedexta | $46 | 2 payments
|
| Alexion Pharmaceuticals | Soliris | $43 | 3 payments
|
| Lilly USA | Emgality | $30 | 2 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $18 | 1 payment
|
| Kyowa Kirin | Nourianz | $16 | 1 payment
|
2019: $1,075
| EMD Serono | Mavenclad | $229 | 25 payments
|
| Ucb | Briviact | $163 | 6 payments
|
| Novartis Pharmaceuticals | Mayzent | $151 | 7 payments
|
| Alexion Pharmaceuticals | Soliris | $121 | 7 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $116 | 17 payments
|
| Amgen | Aimovig | $90 | 3 payments
|
| Sunovion Pharmaceuticals | Aptiom | $47 | 7 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $44 | 2 payments
|
| Eisai | Fycompa | $33 | 2 payments
|
| Pfizer | Lyrica | $28 | 2 payments
|
| Lilly USA | Emgality | $24 | 1 payment
|
| Acorda Therapeutics | Inbrija | $17 | 1 payment
|
| Omeros | Omidria | $12 | 1 payment
|
Professional record
- NPI
- 1851352264
- Licence
- CA A69469California A69469: Current · expires 2027-03-31
- Trained
- Tufts University School of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 325 Distel Cir Fl 2, Los Altos, CA, 94022
- NPI first listed
- 2006-03-28
- NPI last updated
- 2020-05-29
- NPI record certified
- 2020-05-29
This is when the NPI record was last certified, not a medical board exam.